Monoclonal Antibodies in Gynecological Cancer: A Critical Point of View

During the last decades, several improvements in treating gynecological malignancies have been achieved. In particular, target therapies, mostly monoclonal antibodies, have emerged as an attractive option for the treatment of these malignancies. In fact, various molecular-targeted agents have been d...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellati, Filippo, Napoletano, Chiara, Gasparri, Maria Luisa, Visconti, Valeria, Zizzari, Ilaria Grazia, Ruscito, Ilary, Caccetta, Jlenia, Rughetti, Aurelia, Benedetti-Panici, Pierluigi, Nuti, Marianna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253445/
https://www.ncbi.nlm.nih.gov/pubmed/22235224
http://dx.doi.org/10.1155/2011/890758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253445/
https://www.ncbi.nlm.nih.gov/pubmed/22235224
http://dx.doi.org/10.1155/2011/890758

Ejemplares similares